Follow this blog:
RSS

Stomach staples may work better than pills when controlling diabetes

By | March 27, 2012, 10:05 AM PDT

Two new studies out this week in the New England Journal of Medicine (NEJM) have found that bariatric surgery may lead to better outcomes for type 2 diabetes patients than medical therapies.

Type 2 diabetes, or adult-onset diabetes, is a chronic disease where you have too much sugar (glucose) in your blood. It usually develops in people who are overweight or elderly. As I wrote earlier this month, diabetes happens when your body has trouble making or using insulin.

One of the studies, out of Italy, compared diabetes patients who’d had standard medical therapy with those who’d had bariatric surgery. Bariatric surgery shrinks the stomach and forces food to skip part of the small intestine, so patients feel full faster and absorb less calories from the food they do eat. The surgery patients stopped taking hypoglycemia pills and insulin within 15 days of the operation. Two years after surgery, they showed 75%-95% remission of diabetes, compared to 0% of the standard medical therapy patients.

The other study, out of Cleveland, compared bariatric surgery patients with those who’d had intensive medical therapy for diabetes. A year after surgery:

  • Post-op patients should a significantly reduced reliance on drugs to control their blood glucose levels, compared to the medical therapy patients.
  • A much greater percentage of the surgery patients achieved healthy blood glucose levels.
  • Surgery patients showed significantly greater sustained weight loss than the non-surgery patients.

Researchers say that bariatric surgery not only improves patient health by helping them lose weight, it also modifies the levels of gut hormones used to metabolize sugars and fats.

An editorial in NEJM predicts these studies will have a major effect on future diabetes treatment, and may urge doctors to recommend bariatric surgery sooner for diabetes patients.

The American Diabetes Association (ADA), however, says the studies will not alter their recommendations. Dr. Vivian Fonseca of the ADA told the New York Times that the studies are too small in sample size to be seen as definitive.

[via New York Times and Time.com]

Photo: Official Navy Page/Flickr

Start your week smarter with our weekly e-mail newsletter. It's your cheat sheet for good ideas. Get it.

Audrey Quinn

About Audrey Quinn

Audrey Quinn is a contributing editor for SmartPlanet.

Audrey Quinn

Audrey Quinn
Contributing Editor

Audrey Quinn is a multimedia science journalist based in Brooklyn, New York. She has corresponded for PRI's The World, Radiolab, Deutsche Welle's Living Planet, and a number of NPR affiliate stations. She also produces and hosts a podcast for the Mind Science Foundation. Previously, she performed neuroscience research at the University of Washington Autism Center and the Seattle VA Hospital.

Follow her on Twitter.

Audrey Quinn

Audrey Quinn

Audrey does not have financial holdings that would influence how or what she covers.

She writes for SmartPlanet and is not an employee of CBS.

If you liked this, don't miss...
The discussion hasn’t started yet. Why don’t you begin it?
Formatting +
BB Codes - Note: HTML is not supported in forums
  • [b] Bold [/b]
  • [i] Italic [/i]
  • [u] Underline [/u]
  • [s] Strikethrough [/s]
  • [q] "Quote" [/q]
  • [ol][*] 1. Ordered List [/ol]
  • [ul][*] · Unordered List [/ul]
  • [pre] Preformat [/pre]
  • [quote] "Blockquote" [/quote]

Join the SmartPlanet community and join the conversation! Signing up is fast and free. Don't wait -- we want to hear your opinion!